137 related articles for article (PubMed ID: 30240885)
1. Initiating yellow jacket venom immunotherapy with a 100-μg dose: A challenge?
Vos BJPR; Dubois AEJ; Rauber MM; Pfützner W; Miehe M; Bohle B; Möbs C; Oude Elberink JNG
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1332-1334.e4. PubMed ID: 30240885
[No Abstract] [Full Text] [Related]
2. Wasp Venom Immunotherapy in a Patient With Immune-Mediated Inflammatory Central Nervous System Disease: Is it Safe?
Nittner-Marszalska M; Kowal A; Szewczyk P; Guranski K; Ejma M
J Investig Allergol Clin Immunol; 2017; 27(2):127-129. PubMed ID: 28398199
[No Abstract] [Full Text] [Related]
3. Pre-emptive Evaluation of Venom Allergy in a Patient with Systemic Mastocytosis.
Gülen T; Akin C
Acta Derm Venereol; 2018 Jan; 98(1):149-150. PubMed ID: 28902950
[No Abstract] [Full Text] [Related]
4. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
[No Abstract] [Full Text] [Related]
5. Successful venom immunotherapy to paper wasp, in IgE-venom negative patient.
Vovolis V; Mikos N; Koutsostathis N
Allergol Immunopathol (Madr); 2011; 39(1):57-8. PubMed ID: 20655651
[No Abstract] [Full Text] [Related]
6. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
7. [Allergy to bee and yellow jacket venoms].
Saari S; Kalimo K; Viander M; Henriksson S
Duodecim; 1985; 101(4):393-401. PubMed ID: 3979324
[No Abstract] [Full Text] [Related]
8. Honeybee and wasp venom allergy: Sensitization and immunotherapy.
Adib-Tezer H; Bayerl C
J Dtsch Dermatol Ges; 2018 Oct; 16(10):1228-1247. PubMed ID: 30300499
[TBL] [Abstract][Full Text] [Related]
9. Venom immunotherapy: worth the time and trouble!
Heddle RJ; Brown SG
Clin Exp Allergy; 2009 Jun; 39(6):774-6. PubMed ID: 19533838
[No Abstract] [Full Text] [Related]
10. Venom immunotherapy (VIT): clinical efficacy and improvement in quality of life.
Oude Elberink J
Drugs Today (Barc); 2008 Dec; 44 Suppl B():43-5. PubMed ID: 19221618
[No Abstract] [Full Text] [Related]
11. [Results of hyposensitization with bee and wasp venom].
Adolph J; Dehnert I; Fischer JF; Wenz W
Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings.
Oude Elberink JN; van der Heide S; Guyatt GH; Dubois AE
Clin Exp Allergy; 2009 Jun; 39(6):883-9. PubMed ID: 19364334
[TBL] [Abstract][Full Text] [Related]
14. [Fatal reaction to wasp sting in a patient allergic to wasp venom].
Mark CK; Grøfte T; Shim J
Ugeskr Laeger; 2015 Apr; 177(17):. PubMed ID: 25922165
[TBL] [Abstract][Full Text] [Related]
15. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom.
Oude Elberink JN; De Monchy JG; Van Der Heide S; Guyatt GH; Dubois AE
J Allergy Clin Immunol; 2002 Jul; 110(1):174-82. PubMed ID: 12110838
[TBL] [Abstract][Full Text] [Related]
16. Limited ability of recombinant Hymenoptera venom allergens to resolve IgE double sensitization.
Šelb J; Bidovec Stojković U; Bajrović N; Kopač P; Eržen R; Zidarn M; Košnik M; Korošec P
J Allergy Clin Immunol Pract; 2018; 6(6):2118-2120. PubMed ID: 29802909
[No Abstract] [Full Text] [Related]
17. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
[No Abstract] [Full Text] [Related]
18. Fatal anaphylactic sting reaction in a patient with mastocytosis.
Wagner N; Fritze D; Przybilla B; Hagedorn M; Ruëff F
Int Arch Allergy Immunol; 2008; 146(2):162-3. PubMed ID: 18204283
[TBL] [Abstract][Full Text] [Related]
19. Expanding indications of omalizumab therapy in the absence of specific IgE.
Khan S; Deacock S
Allergol Immunopathol (Madr); 2011; 39(3):189. PubMed ID: 21470760
[No Abstract] [Full Text] [Related]
20. Tolerated wasp sting challenge improves health-related quality of life in patients allergic to wasp venom.
Fischer J; Teufel M; Feidt A; Giel KE; Zipfel S; Biedermann T
J Allergy Clin Immunol; 2013 Aug; 132(2):489-90. PubMed ID: 23639308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
